Global Etamsylate (Ethamsylate) Market Size By Type (Tablet, Injection), By Application (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2023 to 2032

Report Id: 32958 | Published Date: Apr 2026 | No. of Pages: | Base Year for Estimate: Apr 2026 | Format:


lobal Etamsylate (Ethamsylate) Market Report Description


The Global Etamsylate (Ethamsylate) Market was valued at USD 430 million in 2023 and is projected to reach USD 670 million by 2031, expanding at a CAGR of 5.7% during the forecast period from 2023 to 2031. Etamsylate is widely used as a hemostatic agent to prevent and control capillary bleeding across clinical, surgical, gynecological, and dental applications. The market growth is fueled by the increasing demand for anti-hemorrhagic drugs in developing healthcare sectors, rising surgical volumes globally, and growing awareness regarding rare bleeding disorders.

Drivers

1. Rising Incidence of Surgical Procedures:

With the growing global geriatric population and higher prevalence of chronic diseases requiring surgical intervention, the use of Etamsylate as a bleeding control agent is expanding rapidly in clinical settings.

2. Increased Awareness of Hemostatic Management:

Awareness initiatives and medical training programs around hemostatic emergencies have led to higher adoption of Etamsylate in both emergency and elective procedures, especially in emerging healthcare markets.

3. Expanding Gynecological Applications:

Etamsylate is increasingly used in the treatment of menorrhagia and postpartum hemorrhage, both common complications in women's health, thus contributing significantly to market demand.

Restraints

1. Availability of Alternative Therapies:

The presence of more advanced recombinant and plasma-derived therapies, including tranexamic acid and desmopressin, poses a challenge to the widespread adoption of Etamsylate.

2. Limited Regulatory Approvals in North America:

Etamsylate is not approved in countries like the U.S. and Canada, which restricts its potential market size and limits penetration into high-income markets with significant healthcare expenditure.

Opportunity

1. Market Penetration in Developing Countries:

Emerging economies in Asia, Africa, and Latin America with limited access to high-cost bleeding control agents offer significant growth potential for Etamsylate due to its affordability and broad-spectrum hemostatic effects.

2. Increasing Focus on Emergency and Trauma Care:

Global investment in trauma care and emergency preparedness, especially post-pandemic, is creating a favorable environment for the use of rapid-onset hemostatic agents such as Etamsylate.

Market by System Type Insights

Based on system type, the Tablet Formulation segment accounted for the largest revenue share in 2023 due to its non-invasive nature, cost-effectiveness, and ease of administration. However, the Injectable Formulation segment is expected to register the fastest growth during the forecast period owing to its rapid onset of action and expanding use in hospital and emergency room settings.

Market by End-use Insights

By end use, Hospitals and Clinics dominated the market in 2023, accounting for over 60% of global revenue, owing to the high utilization of Etamsylate in surgical and acute care settings. The Gynecology Centers segment is expected to witness significant growth due to increased usage in managing menstrual and obstetric bleeding.

Market by Regional Insights

Geographically, Asia-Pacific led the market in 2023 and is expected to continue dominating due to high population density, increasing surgical volumes, and broader regulatory acceptance of Etamsylate. Meanwhile, Latin America is projected to experience the fastest CAGR, driven by public health investments and demand for affordable hemostatic agents.

Competitive Scenario

Key players in the Global Etamsylate Market include Ciron Drugs & Pharmaceuticals, Alchem International, Abbott Laboratories, Omega Pharma, Cipla Ltd., and Medinova Pharmaceuticals. These companies are focusing on regional expansion, product availability in public health tenders, and research on new therapeutic indications.

Scope of Work – Global Etamsylate (Ethamsylate) Market

Report Metric

Details

Market Size (2023)

USD 430 million

Projected Market Size (2031)

USD 670 million

CAGR (2023–2031)

5.7%

Market Segments

By System Type (Tablet, Injection), By End-Use (Hospitals & Clinics, Gynecology Centers, Emergency Care)

Growth Drivers

Rising surgical volumes, expanding gynecological applications, increasing awareness of hemostatic management

Opportunities

Penetration in emerging markets, expansion of trauma and emergency care infrastructure

Key Market Developments

2023: Cipla Ltd. expanded its Etamsylate product line in Southeast Asia, targeting post-partum hemorrhage and surgical bleeding management.

2024: Abbott Laboratories launched a combined formulation therapy using Etamsylate and Tranexamic Acid for advanced hemostatic efficacy in select European markets.

2025: Omega Pharma announced a licensing agreement for Etamsylate-based products in public healthcare programs across Latin America.

FAQs

1) What is the current market size of the Global Etamsylate (Ethamsylate) Market?

The market size was USD 430 million in 2023.

2) What is the major growth driver of the Global Etamsylate (Ethamsylate) Market?

The increasing number of surgical procedures and rising awareness of bleeding control are key growth drivers.

3) Which is the largest region during the forecast period in the Global Etamsylate (Ethamsylate) Market?

Asia-Pacific is projected to be the largest region throughout the forecast period.

4) Which segment accounted for the largest market share in Global Etamsylate (Ethamsylate) Market?

Tablet Formulation accounted for the largest market share in 2023.

5) Who are the key market players in the Global Etamsylate (Ethamsylate) Market?

Key players include Cipla Ltd., Ciron Drugs & Pharmaceuticals, Abbott Laboratories, Medinova Pharmaceuticals, and Omega Pharma.

Let me know if you'd like this in DOCX or PDF format, or if you need another report. 

Download Sample Report

Speak with an analyst to get exclusive insights tailored to your needs

Related Reports

Related report image
Global Venous thromboembolism(VTE)Therapeutics Market By Type (Deep Vein Thrombosis(DVT),Pulmonary E...

The Global Venous Thromboembolism (VTE) Therapeutics Market was valued at USD 1.8 billion in 2023 an...

Read More
Related report image
Global Vein Illumination Device Market By Type (Transillumination, Infrared Technology, Ultrasound)...

The Global Vein Illumination Device Market was valued at USD 200 million in 2023 and is projected to...

Read More
Related report image
Global Vasculitis Treatment Market By Type (Large Vasculitis Treatment, Medium Vasculitis Treatment,...

The Global Vasculitis Treatment Market was valued at USD 500 million in 2023 and is projected to rea...

Read More
Related report image
Global Vascular Guidewires Market By Type (Nitinol, Stainless Steel, Hybrid), By Application (Hospi...

The Global Vascular Guidewires Market was valued at USD 1.3 billion in 2023 and is projected to reac...

Read More
Related report image
Global Vagus nerve stimulation Market By Type (Implantable VNS Devices, External VNS Devices), By Ap...

The Global Vagus Nerve Stimulation (VNS) Market was valued at USD 625 million in 2023 and is projec...

Read More
Related report image
Global In-line UV-Vis Spectroscopy Market By Type (Color Measurement, Chemical Concentration, Turbid...

The In-line UV-Vis Spectroscopy Market is expected to grow at a CAGR of 10.2% between 2023 and 2030,...

Read More
Related report image
Global Venturi Masks Market By Type (24% Oxygen Masks, 28% Oxygen Masks, 31% Oxygen Masks, 35% Oxyge...

Between the years 2023 and 2030, it is anticipated that the Global Venturi Masks Market will experie...

Read More
Related report image
Global Knee Massager Market By Type (Knee Massager,Knuckle Massager,Elbow Massager), By Application...

The growing awareness of joint health and the rising incidence of knee-related conditions like arthr...

Read More
Related report image
Global Mechanical Thrombectomy Devices Market By Type (Stroke, Deep Vein Thrombosis (DVT), Pulmonary...

The Global Mechanical Thrombectomy Devices Market was valued at USD 1.3 billion in 2023 and is proje...

Read More
Related report image
Global Vaginal Slings Market By Type (Biologic, Synthetic Slings), By Application (Clinics, Hospital...

The Global Vaginal Slings Market was valued at USD 1.1 billion in 2023 and is projected to reach USD...

Read More